Top 10 FDA Recalls Physicians Should Know - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Top 10 FDA Recalls Physicians Should Know

A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.

  • By

  • mdspire news news staff

  • June 18, 2026

  • 5 min

Share

Clinical Report: Top 10 FDA Recalls Physicians Should Know

Background

FDA recalls are critical for ensuring patient safety and effective clinical management. Healthcare providers must stay informed about recalls to mitigate risks associated with compromised medications and devices.

Data Highlights

ProductRecall ClassIssueActions Required
Fentanyl Citrate Sterile InjectionClass IISubpotent drugCease use of affected lot
Automated Impella ControllerClass IDelayed alarm displayUpdate software to version 10.1 or later
Insulet Insulin PumpClass ITear in internal tubingStop using affected Pods, replace with non-affected
Baxter Positive Pressure Breathing DeviceClass IUpdated instructions for useReview updated instructions, monitor patients
Philips Trilogy Evo VentilatorClass IInaccurate tidal volume deliveryStop using nonpneumatic nebulizers, update devices

Key Findings

  • Fentanyl citrate sterile injection recalled due to subpotency.
  • Automated Impella Controllers may delay alarm displays, requiring software updates.
  • Insulet's Omnipod 5 Pods recalled for potential underdelivery of insulin.
  • Baxter's Blue Ventilator Adapter Module recall involves updated usage instructions.
  • Philips Trilogy Evo ventilators may deliver inaccurate tidal volumes when used with nonpneumatic nebulizers.
  • Boston Scientific's AXIOS Stent recall reported serious injuries and mortalities linked to deployment issues.

Clinical Implications

Healthcare providers should remain vigilant regarding FDA recalls to ensure patient safety. Immediate action is required to address the use of affected products and to follow updated guidelines provided by manufacturers.

Conclusion

Staying informed about FDA recalls is essential for healthcare professionals to prevent adverse events and ensure the safe use of medications and devices.

Related Resources & Content

  1. Associated Press Health, AP News, 2023 -- Stores didn't pull ByHeart formula quickly after recall, FDA says
  2. conexiant, Conexiant, 2023 -- Top 10 Clinical Guidance Updates for Physicians
  3. Retinal Physician, Retinal Physician, 2014 -- Ten Months to ICD-10: Will Physicians, Vendors and Payers be Ready?
  4. Understanding Drug Recalls: What to Know and What to Do | FDA, FDA, 2023 -- Understanding Drug Recalls: What to Know and What to Do
  5. Drug Recalls | FDA, FDA, 2023 -- Drug Recalls
  6. ophthalmic professional — Several Ophthalmic Products Are Voluntarily Recalled
  7. Understanding Drug Recalls: What to Know and What to Do | FDA
  8. Drug Recalls | FDA
  9. ISMP List of High-Alert Medications

Original Source(s)

Top 10 FDA Recalls Physicians Should Know

  • by mdspire news news staff

  • June 18, 2026

Related Content

FDA expands weekly insulin use to children

Insulin icodec-abae offers a weekly basal insulin option for pediatric type 2 diabetes, supported by adult trials and pediatric pharmacokinetic data.

Asymptomatic carriage may fuel C difficile spread

Modeling in oncology units attributed 92% of transmission-related colonization to patients without symptomatic infection.

4 societies redefine women's heart care

New multisociety guidance identifies menstrual irregularities as potential early markers of cardiovascular risk, extending prevention efforts into adolescence.